Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder

  1. Arlandis, S.
  2. Castro, D.
  3. Errando, C.
  4. Fernández, E.
  5. Jiménez, M.
  6. González, P.
  7. Crespo, C.
  8. Staeuble, F.
  9. Rodríguez, J.M.
  10. Brosa, M.
Aldizkaria:
Value in Health

ISSN: 1524-4733,  1098-3015

Argitalpen urtea: 2011

Alea: 14

Zenbakia: 2

Orrialdeak: 219-228

Mota: Artikulua

DOI: 10.1016/J.JVAL.2010.08.006 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus